SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities
SEC Accession No. 0001181431-12-002267
Filing Date
2012-01-11
Accepted
2012-01-11 17:41:04
Documents
1
Period of Report
2012-01-10
Filing Date Changed
2012-01-11

Document Format Files

Seq Description Document Type Size
1 KISHBAUCH 01.10.12 SALE rrd330437.html 4  
1 KISHBAUCH 01.10.12 SALE rrd330437.xml 4 12364
  Complete submission text file 0001181431-12-002267.txt   13683
Mailing Address 300 GEORGE STREET NEW HAVEN CT 06511
Business Address 300 GEORGE STREET NEW HAVEN CT 06511 203-624-7000
ACHILLION PHARMACEUTICALS INC (Issuer) CIK: 0001070336 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 18 CHERRYVILLE RD FLEMINGTON NJ 08822
Business Address
KISHBAUCH MICHAEL D (Reporting) CIK: 0001076979 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33095 | Film No.: 12522777